4.6 Article

In vitro Reconstitution of Peptidoglycan Assembly from the Gram-Positive Pathogen Streptococcus pneumoniae

期刊

ACS CHEMICAL BIOLOGY
卷 8, 期 12, 页码 2688-2696

出版社

AMER CHEMICAL SOC
DOI: 10.1021/cb400575t

关键词

-

资金

  1. Coopol innovation France-Chine program
  2. Medical Research Council [G500643, G0600801]
  3. ADR from the Region Rhone-Alpes [ARC1]
  4. University of Warwick Ph.D. studentship
  5. Medical Research Council [G0600801] Funding Source: researchfish
  6. MRC [G0600801] Funding Source: UKRI

向作者/读者索取更多资源

Understanding the molecular basis of bacterial cell wall assembly is of paramount importance in addressing the threat of increasing antibiotic resistance worldwide. Streptococcus pneumoniae presents a particularly acute problem in this respect, as it is capable of rapid evolution by homologous recombination with related species. Resistant strains selected by treatment with beta-lactams express variants of the target enzymes that do not recognize the drugs but retain their activity in cell wall building, despite the antibiotics being mimics of the natural substrate.. Until now, the crucial transpeptidase activity that is inhibited by beta-lactams was not amenable to in vitro investigation with enzymes from Gram-positive organisms, including streptococci, staphylococci, or enterococci pathogens. We report here for the first time the in vitro assembly of peptidoglycan using recombinant penicillin-binding proteins from pneumococcus and the precursor lipid II. The two required enzymatic activities, glycosyl transferase for elongating glycan chains and transpeptidase for cross-linking stem-peptides, were observed. Most importantly, the transpeptidase activity was dependent on the chemical nature of the stem-peptide. Amidation of the second residue glutamate into iso-glutamine by the recently discovered amido-transferase MurT/GatD is required for efficient cross-linking of the peptidoglycan.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据